The litigation alleges that PROCEPT misled shareholders by implementing an aggressive discount program that incentivized bulk orders of handpieces beyond actual procedure demand. According to the complaint, this strategy artificially inflated the company's reported U.S. sales and revenue by pulling forward figures from future periods. By the end of the class period, the firm reportedly accumulated more than 10,000 units of excess field inventory.
In section Releases
Investors Face September Deadline in PROCEPT BioRobotics Fraud Suit
Investors who incurred significant financial losses in PROCEPT BioRobotics Corporation between February 2024 and February 2026 have until September 22, 2026, to seek appointment as lead plaintiff in a pending class action lawsuit filed by the Law Offices of Howard G. Smith.
The lawsuit asserts that these practices, which went undisclosed to the public, resulted in materially overstated financial metrics and obscured risks to the company's operational stability. Investors wishing to discuss their legal rights or participate in the class action may contact the Law Offices of Howard G. Smith at 215-638-4847 or via their firm website.
Comments (0)
No comments yet. Be the first!